Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis.
作者信息
Imamura Teruhiko, Nakamura Makiko
机构信息
Second Department of Internal Medicine, University of Toyama Toyama Japan.
出版信息
Circ Rep. 2021 Nov 11;3(12):748. doi: 10.1253/circrep.CR-21-0120. eCollection 2021 Dec 10.
Abstract
摘要
相似文献
1
Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis.女性心脏淀粉样变性患者的诊断与治疗策略
Circ Rep. 2021 Nov 11;3(12):748. doi: 10.1253/circrep.CR-21-0120. eCollection 2021 Dec 10.
2
Diagnostic and prognostic value of cardiac imaging in amyloidosis.心脏成像在淀粉样变性中的诊断和预后价值。
World J Cardiol. 2020 Dec 26;12(12):599-614. doi: 10.4330/wjc.v12.i12.599.
3
Cardiac Amyloidosis: Presentations, Diagnostic Work-up and Collaborative Approach for Comprehensive Clinical Management.心脏淀粉样变：临床表现、诊断方法及全面临床管理的协作方法。
Curr Probl Cardiol. 2021 Oct;46(10):100910. doi: 10.1016/j.cpcardiol.2021.100910. Epub 2021 May 29.
4
A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.一种多模态诊断模型提高了经心脏活检确诊的患者中心脏淀粉样变性的检测率。
Am Heart J. 2021 Feb;232:137-145. doi: 10.1016/j.ahj.2020.11.006. Epub 2020 Nov 17.
5
Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis.疑似心脏淀粉样变性患者心血管磁共振成像的诊断准确性：一项系统评价和荟萃分析
BMC Cardiovasc Disord. 2016 Jun 7;16:129. doi: 10.1186/s12872-016-0311-6.
6
Analysis of diagnostic and therapeutic strategies in advanced cardiac light-chain amyloidosis.分析晚期心脏轻链淀粉样变性的诊断和治疗策略。
J Heart Lung Transplant. 2016 Aug;35(8):995-1002. doi: 10.1016/j.healun.2016.03.004. Epub 2016 Mar 17.
7
Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis.心肌肌钙蛋白 T 水平对心肌淀粉样变性患者的诊断价值。
ESC Heart Fail. 2018 Feb;5(1):27-35. doi: 10.1002/ehf2.12203. Epub 2017 Sep 4.
8
Diagnostic and prognostic value of subcutaneous tissue biopsy in patients with cardiac amyloidosis.皮下组织活检对心脏淀粉样变性患者的诊断和预后价值。
Am J Cardiol. 2012 Nov 15;110(10):1507-11. doi: 10.1016/j.amjcard.2012.06.059. Epub 2012 Aug 3.
9
Diagnostic score of cardiac involvement in AL amyloidosis.AL 淀粉样变性心脏受累的诊断评分。
Eur Heart J Cardiovasc Imaging. 2020 May 1;21(5):542-548. doi: 10.1093/ehjci/jez180.
10
Cardiac Amyloidosis in Patients Undergoing TAVR: Why We Need to Think About It.接受经导管主动脉瓣置换术（TAVR）患者的心脏淀粉样变性：为何我们需要予以关注。
Cardiovasc Revasc Med. 2021 Jan;22:109-114. doi: 10.1016/j.carrev.2020.06.005. Epub 2020 Jun 10.
本文引用的文献
1
Wild-Type Transthyretin Amyloidosis in Female Patients - Consideration of Sex Differences.女性患者的野生型转甲状腺素蛋白淀粉样变性——性别差异的考量
Circ Rep. 2021 Jun 29;3(8):465-471. doi: 10.1253/circrep.CR-21-0067. eCollection 2021 Aug 10.
2
Initial Experience With Tafamidis Treatment for Transthyretin Amyloid Cardiomyopathy.塔非酰胺治疗转甲状腺素蛋白淀粉样心肌病的初步经验。
Circ Rep. 2020 Jul 21;2(8):420-424. doi: 10.1253/circrep.CR-20-0062.
3
Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis.心脏淀粉样变性中神经激素拮抗的安全性和耐受性。
Eur J Intern Med. 2020 Oct;80:66-72. doi: 10.1016/j.ejim.2020.05.015. Epub 2020 May 29.
Zotero 插件